Insider · CIK 0001125857

GLUSKIN ANNA E

Reports to the SEC for 2 companies · TORONTO, A6

sec.gov

Transactions

Companies

Filings

CIK

0001125857

Forms 4 and 5

Insider transactions

27 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-11-16	GENEREX BIOTECHNOLOGY CORPP Purchase	Director, CEO & President	PPurchase	+10K sh	$0.51	+$5,100	226,127
2015-01-05	EASTGATE BIOTECH CORPP Purchase	Director	PPurchase	+1.24M sh	$0.04	+$49.8K	12,193,688
2015-01-05	EASTGATE BIOTECH CORPWARRANTP Purchase	Director	PPurchase	+1.24M sh	$0.04	+$49.8K	2,251,750
2014-06-09	EASTGATE BIOTECH CORPWarrantP Purchase	Director	PPurchase	+360K sh	$0.25	+$90K	1,008,000
2014-06-09	EASTGATE BIOTECH CORPP Purchase	Director	PPurchase	+480K sh	$0.25	+$120K	4,844,000
2014-03-21	EASTGATE BIOTECH CORPP Purchase	Director	PPurchase	+864K sh	$0.25	+$216K	4,364,000
2014-03-21	EASTGATE BIOTECH CORPWarrantP Purchase	Director	PPurchase	+648K sh	$0.25	+$162K	648,000
2010-03-08	GENEREX BIOTECHNOLOGY CORPCommon Stock Purchase Option (right to buy)A Award	Director, CEO & President	AAward	+500K sh	—	—	500,000
2009-10-20	GENEREX BIOTECHNOLOGY CORPCommon Stock Purchase Option (right to buy)D Disposition to Issuer	Director, CEO & President	DDisposition to Issuer	−1.12M sh	—	—	0
2009-10-20	GENEREX BIOTECHNOLOGY CORPCommon Stock Purchase Option (right to buy)A Award	Director, CEO & President	AAward	+1.12M sh	—	—	1,120,704
2009-10-20	GENEREX BIOTECHNOLOGY CORPCommon Stock Purchase Option (right to buy)D Disposition to Issuer	Director, CEO & President	DDisposition to Issuer	−250K sh	—	—	0
2009-10-20	GENEREX BIOTECHNOLOGY CORPCommon Stock Purchase Option (right to buy)A Award	Director, CEO & President	AAward	+250K sh	—	—	250,000
2005-04-05	GENEREX BIOTECHNOLOGY CORPCommon Stock Purchase OptionsA Award	Director, CEO & President	AAward	+1.12M sh	—	—	1,120,705
2005-04-05	GENEREX BIOTECHNOLOGY CORPCommon Stock Purchase OptionsA Award	Director, CEO & President	AAward	+250K sh	—	—	250,000
2004-01-23	GENEREX BIOTECHNOLOGY CORPP Purchase	Director, CEO & President	PPurchase	+500 sh	$1.71	+$855	16,500
2003-12-01	GENEREX BIOTECHNOLOGY CORPP Purchase	Director, CEO & President	PPurchase	+500 sh	$1.56	+$780	16,500
2003-11-24	GENEREX BIOTECHNOLOGY CORPP Purchase	Director, CEO & President	PPurchase	+500 sh	$1.63	+$815	16,000
2003-11-19	GENEREX BIOTECHNOLOGY CORPP Purchase	Director, CEO & President	PPurchase	+500 sh	$1.65	+$825	15,500
2003-11-10	GENEREX BIOTECHNOLOGY CORPP Purchase	Director, CEO & President	PPurchase	+500 sh	$1.82	+$910	15,000
2003-11-10	GENEREX BIOTECHNOLOGY CORPP Purchase	Director, CEO & President	PPurchase	+500 sh	$1.81	+$905	14,500
2003-11-07	GENEREX BIOTECHNOLOGY CORPP Purchase	Director, CEO & President	PPurchase	+300 sh	$1.82	+$546	663,500
2003-11-07	GENEREX BIOTECHNOLOGY CORPP Purchase	Director, CEO & President	PPurchase	+500 sh	$1.81	+$905	664,000
2003-11-07	GENEREX BIOTECHNOLOGY CORPP Purchase	Director, CEO & President	PPurchase	+200 sh	$1.85	+$370	663,200
2002-11-26	GENEREX BIOTECHNOLOGY CORPCommon Stock Purchase OptionsA Award	Director, CEO & President	AAward	+350K sh	—	—	350,000
2002-01-25	GENEREX BIOTECHNOLOGY CORPP Purchase	Director, CEO & President	PPurchase	—	—	—	—
2002-01-22	GENEREX BIOTECHNOLOGY CORPP Purchase	Director, CEO & President	PPurchase	—	—	—	—
2002-01-22	GENEREX BIOTECHNOLOGY CORPP Purchase	Director, CEO & President	PPurchase	—	—	—	—

Recent filings

Accepted (ET)
Jan 214
EASTGATE ACQUISITIONS CORP0001125857-15-000001
SEC(opens sec.gov)
Jul 144
EASTGATE ACQUISITIONS CORP0001125857-14-000006
SEC(opens sec.gov)
Mar 314
EASTGATE ACQUISITIONS CORP0001125857-14-000001
SEC(opens sec.gov)
Mar 104
GLUSKIN ANNA E0001144204-10-012523
SEC(opens sec.gov)
Nov 164
GLUSKIN ANNA E0001144204-09-059725
SEC(opens sec.gov)
Apr 74
GENEREX BIOTECHNOLOGY CORP0000950116-05-001317
SEC(opens sec.gov)
Jan 234
GENEREX BIOTECHNOLOGY CORP0000950116-04-000256
SEC(opens sec.gov)
Dec 34
GENEREX BIOTECHNOLOGY CORP0000950116-03-004716
SEC(opens sec.gov)
Nov 254
GENEREX BIOTECHNOLOGY CORP0000950116-03-004653
SEC(opens sec.gov)
Nov 204
GENEREX BIOTECHNOLOGY CORP0000950116-03-004620
SEC(opens sec.gov)
Nov 124
GENEREX BIOTECHNOLOGY CORP0000950116-03-004438
SEC(opens sec.gov)
Nov 124
GENEREX BIOTECHNOLOGY CORP0000950116-03-004452
SEC(opens sec.gov)

Companies

Address

33 HARBOUR SQUARE, SUITE 202

TORONTO, A6, M5J 2G2